Latest / Health & Veritas: Yale's Healthcare and Health Policy Podcast
Jerry Avorn: Countering the Drug Marketing Machine
Howie and Harlan are joined by Harvard internist Jerry Avorn to discuss his research on the pharmaceutical industry and his work promoting evidence-based prescribing. Harlan highlights new results from the American Heart Association meeting, including a one-time CRISPR-based therapy for high cholesterol; Howie reports on an outbreak of infant botulism.
Show notes:
Research from the American Heart Association Meeting
"Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3"
"First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides"
"Cardiac Allograft…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.